Danya Zhang
Wuhan, 430000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Cucurbitacin I induces immunogenic cell death and synergistically potentiates cisplatin efficacy in epithelial ovarian cancer.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: May 13, 2025
TMTP1-modified polymeric micelles for the inhibition of ovarian cancer metastasis and recurrence through enhanced photothermal-immunotherapy.
Journal: Materials today. Bio
Published: February 02, 2025
TMTP1-modified nanocarrier boosts cervical cancer immunotherapy by eliciting pyroptosis.
Journal: Theranostics
Published: December 06, 2024
SNS‑032 combined with decitabine induces caspase‑3/gasdermin E‑dependent pyroptosis in breast cancer cells.
Journal: Oncology letters
Published: September 05, 2024
Gambogic acid induces GSDME dependent pyroptotic signaling pathway via ROS/P53/Mitochondria/Caspase-3 in ovarian cancer cells.
Journal: Biochemical pharmacology
Published: August 15, 2024
A TMVP1-modified near-infrared nanoprobe: molecular imaging for tumor metastasis in sentinel lymph node and targeted enhanced photothermal therapy.
Journal: Journal of nanobiotechnology
Published: February 09, 2023
Gambogic Acid Induces Pyroptosis of Colorectal Cancer Cells through the GSDME-Dependent Pathway and Elicits an Antitumor Immune Response.
Journal: Cancers
Published: September 17, 2022
A novel ICG-labeled cyclic TMTP1 peptide dimer for sensitive tumor imaging and enhanced photothermal therapy in vivo.
Journal: European journal of medicinal chemistry
Published: August 20, 2021
TMTP1-Modified, Tumor Microenvironment Responsive Nanoparticles Co-Deliver Cisplatin and Paclitaxel Prodrugs for Effective Cervical Cancer Therapy.
Journal: International journal of nanomedicine
Published: December 31, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026